HEMISPHERX BIOPHARMA INC's ticker is HEB and the CUSIP is 42366C103. A total of 22 filers reported holding HEMISPHERX BIOPHARMA INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $0 | -100.0% | 4,396 | -57.7% | 0.00% | – |
| Q3 2015 | $2,000 | 0.0% | 10,396 | 0.0% | 0.00% | – |
| Q2 2015 | $2,000 | -50.0% | 10,396 | -50.0% | 0.00% | – |
| Q1 2015 | $4,000 | +33.3% | 20,792 | +100.0% | 0.00% | – |
| Q4 2014 | $3,000 | 0.0% | 10,396 | 0.0% | 0.00% | – |
| Q3 2014 | $3,000 | 0.0% | 10,396 | 0.0% | 0.00% | – |
| Q2 2014 | $3,000 | -25.0% | 10,396 | 0.0% | 0.00% | – |
| Q1 2014 | $4,000 | +33.3% | 10,396 | 0.0% | 0.00% | – |
| Q4 2013 | $3,000 | +50.0% | 10,396 | 0.0% | 0.00% | – |
| Q3 2013 | $2,000 | 0.0% | 10,396 | 0.0% | 0.00% | – |
| Q2 2013 | $2,000 | – | 10,396 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEDBUSH SECURITIES INC | 156,500 | $41,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 524,476 | $139,000 | 0.00% |
| Investors Capital Advisory Services | 17,000 | $4,000 | 0.00% |
| Joel Isaacson & Co., LLC | 15,500 | $4,000 | 0.00% |
| CITY HOLDING CO | 5,000 | $1,000 | 0.00% |
| UBS AG | 10,110 | $3,000 | 0.00% |
| NOMURA HOLDINGS INC | 1,400 | $0 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 288,100 | $76,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 30,506 | $8,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 10,396 | $3,000 | 0.00% |